Foundation Medicine at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Foundation Medicine brings 3 presentations to AMP 2026 in Seattle, and exhibits at Booth 1701, MR14. Its sessions cover molecular residual disease in breast cancer and the surveillance decisions that follow, plus HLA class I typing drawn from comprehensive genomic profiling. It also joins an education session on adapting communication strategies for today's pathology learners.
| Organization | AMP 2026 Attendance |
|---|---|
Foundation Medicine Boston, MA | |
Molecular information company providing comprehensive genomic profiling to inform cancer treatment decisions. | Booth Exhibiting at Booth 1701, MR14 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 8:00am–8:50am Molecular Residual Disease in Breast Cancer: Advancing Surveillance and Clinical Decision-Making Tissue-informed circulating tumor DNA testing in breast cancer, from baseline through surveillance and early recurrence detection. Workshop Wed, Nov 11 9:00am–9:50am Advancing HLA Class I Typing Through Comprehensive Genomic Profiling Adding HLA class I typing to comprehensive genomic profiling, with immuno-oncology uses from checkpoint inhibitors to cell therapy. Talk Thu, Nov 12 7:15am–8:15am Adapting Communication Strategies for Today's Pathology Learners (A Special EdCoP Event) Teaching pathology trainees across generations and learning styles, including feedback and handling performance problems. |
Instantly find 20 buyers from Foundation Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction